BioNTech’s IP team leaders on their role in the race to develop the first covid vaccine

The long read: In an exclusive interview, the German company's James Ryan and Julie Anne Gillespie talk about their once-in-a-career experience of working on a project that will help change the world

Get unlimited access to all IAM content